Diseases of the Colon & Rectum

, Volume 44, Issue 8, pp 1123–1128 | Cite as

Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma

Pathologic findings and clinical implications
  • David Medich
  • James McGinty
  • David Parda
  • Stephen Karlovits
  • Chris Davis
  • Philip Caushaj
  • Barry Lembersky
Original Contributions


PURPOSE: Preoperative chemoradiotherapy followed by radical surgical resection has been the preferred treatment for patients presenting with locally advanced distal rectal carcinoma at our institutions. We postulated that chemoradiotherapy-induced pathologic response of the primary tumor would identify which patients would be candidates for local excision as definitive surgical therapy. METHODS: A retrospective analysis of 60 patients with palpable, locally advanced, distal rectal adenocarcinomas treated from 1995 to 2000 was performed. All patients received preoperative chemoradiotherapy consisting of 5-fluorouracil (325 mg/m2) and leucovorin (20 mg/m2) by bolus infusion on Days 1 through 5 and 29 through 33 delivered concurrently with at least 45.0 to 50.4 Gy of pelvic radiation, followed six to eight weeks later by radical surgery and then adjuvant chemotherapy. RESULTS: Among 60 patients (20 females) there was a mean age of 58.7 (28–84) years. Clinical staging was as follows: Stage II, 14 patients (23 percent); Stage III, 35 patients (58 percent); and Stage IV, 11 patients (18 percent). Pathologic examination revealed that negative margins were obtained in 58 patients (97 percent). Downstaging to T0-2N0 was achieved in 17 patients (28 percent), with five (8 percent) achieving a pathologically complete response. Lymph nodes were positive in 24 patients (40 percent) despite chemoradiotherapy. Pathologic node positivity was found in 0 of 5 pT0 patients, 9 (41 percent) of 22 pT1 or pT2, and 15 (45 percent) of 33 pT3. Clinical stage, tumor size, pathologic stage, and adverse histologic features could not reliably predict pN0 status, except pT0 (5 patients only). CONCLUSIONS: Preoperative chemoradiotherapy often downsizes and downstages locally advanced rectal carcinoma. Neither pretreatment clinical characteristics, response to preoperative chemoradiotherapy, or pathologic features reliably predict pN0 status. Therefore, local excision is not recommended as an alternative to radical surgery for locally advanced adenocarcinoma of the distal rectum regardless of the response of the primary tumor to preoperative chemoradiotherapy.

Key words

Preoperative chemoradiotherapy Rectal adenocarcinoma Local excision 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457–60.Google Scholar
  2. 2.
    Church JM, Raudkivi PJ, Hill GL. The surgical anatomy of the rectum: a review with particular relevance to the hazards of rectal mobilization. Int J Colorectal Dis 1987;2:158–66.Google Scholar
  3. 3.
    Wolmark N, Wieand HS, Hyams DM,et al. Randomized trial of post-operative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388–96.Google Scholar
  4. 4.
    Krook JE, Moertel CG, Gunderson LL,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15.Google Scholar
  5. 5.
    Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465–72.Google Scholar
  6. 6.
    Kim DG, Madoff RD. Transanal treatment of rectal cancer: ablative methods and open resection. Semin Surg Oncol 1998;15:101–13.Google Scholar
  7. 7.
    Steele GD Jr, Herndon JE, Bleday R,et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999;6:433–41.Google Scholar
  8. 8.
    Willett CG, Compton CC, Shellito PC, Efird JT. Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer 1994;73:2716–20.Google Scholar
  9. 9.
    Bleday R, Breen E, Jessup JM, Burgess A, Sentovich SM, Steele G Jr. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum 1997;40:388–92.Google Scholar
  10. 10.
    Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000;231:345–51.Google Scholar
  11. 11.
    Russell AH, Harris J, Rosenberg PJ,et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 2000;46:313–22.Google Scholar
  12. 12.
    Blumberg D, Paty PB, Guillem JG,et al. At patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999;42:881–5.Google Scholar
  13. 13.
    Chakravarti A, Compton C, Shellito PC,et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 1999;230:49–54.Google Scholar
  14. 14.
    Anne' P, Mitchell EP, Ahmad N,et al. Radiosensitization in locally advanced adenocarcinoma of the rectum using combined modality therapy (CMT) with CPT-11, 5-fluorouracil concomitant irradiation [abstract]. Proc Am Soc Clin Oncol 2000;19:A250.Google Scholar
  15. 15.
    Grann A, Minsky BD, Cohen AM,et al. Preliminary results of pre-operative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997;40:515–22.Google Scholar
  16. 16.
    Hyams DM, Mamounas EP, Petrelli N,et al. A clinical trial to evaluate the worth of pre-operative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03. Dis Colon Rectum 1997;40:131–9.Google Scholar
  17. 17.
    Minsky BD, Cohen AM, Enker WE,et al. Pre-operative 5-FU, low-dose leucovorin and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1997;37:289–95.Google Scholar
  18. 18.
    Bosset J, Magnin V, Maingon P,et al. Pre-operative radio/chemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000;46:323–7.Google Scholar
  19. 19.
    Chen E, Mohiuddin M, Brodovsky H, Gishbein G, Marks G. Downstaging of advanced rectal cancer following combined pre-operative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169–75.Google Scholar
  20. 20.
    Janjan NA, Khoo VS, Abbruzzese J,et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999;44:1027–38.Google Scholar
  21. 21.
    Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994;30:845–9.Google Scholar
  22. 22.
    Graham RA, Hackford AW, Wazer DE. Local excision of rectal carcinoma: a safe alternative for more advanced tumors? J Surg Oncol 1999;70:235–8.Google Scholar
  23. 23.
    Rosenthal SA, Yeung RS, Weese JL,et al. Conservative management of extensive low-lying rectal carcinomas with transanal excision and combined pre-operative and post-operative radiation therapy: a report of a phase I–II trial. Cancer 1992;69:335–41.Google Scholar
  24. 24.
    Gerard A, Buyse MS, Nordlinger B,et al. Pre-operative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606–13.Google Scholar
  25. 25.
    Mohiuddin M, Regine WF, Marks GJ, Marks JW. High-dose pre-operative radiation and the challenge of sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys 1998;40:569–74.Google Scholar
  26. 26.
    Kumar A, Scholefield H. Endosonography of the anal canal and rectum. World J Surg 2000;24:208–15.Google Scholar
  27. 27.
    Mohiuddin M, Ahmad N, Marks G. A selective approach to adjunctive therapy for cancer of the rectum. Int J Radiat Oncol Biol Phys 1993;27:765–72.Google Scholar
  28. 28.
    Freyer G, Bossard N, Romestary P,et al. Oxoliplatin, 5 fluorouracil, folinic acid and concombinant irradiation in patients with rectal cancer: a phase I study. Program/Proceedings: American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology 2000;19. Abstract 1012.Google Scholar
  29. 29.
    Pfliffer PK. Concurrent UFT/L-leucovorin, and curative intended radiotherapy (60 Gy) in patients with locally advanced rectal cancer: a phase I/II trial. Program/Proceedings: American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology 2000;19. Abstract 992.Google Scholar
  30. 30.
    Dunst J, Reese T, Frings S,et al. Phase I study of capecitabine combined with standard radiotherapy in patients with rectal cancer. Program/Proceedings: American Society of Clinical Oncology. Alexandria, Va: American Society of Clinical Oncology 2000;19. Abstract 995.Google Scholar
  31. 31.
    Napoleon B, Pujol B, Berger F, Valette PJ, Gerard JP, Souquet JC. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br J Surg 1991;78:785–8.Google Scholar
  32. 32.
    Brodsky J, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 1992;62:322–6.Google Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2001

Authors and Affiliations

  • David Medich
    • 1
  • James McGinty
    • 1
  • David Parda
    • 1
  • Stephen Karlovits
    • 1
  • Chris Davis
    • 1
  • Philip Caushaj
    • 1
  • Barry Lembersky
    • 1
  1. 1.From the West Penn Allegheny Health SystemPittsburgh

Personalised recommendations